Companies / BioLamina
BioLamina
Stockholm, Sweden
BioLamina provides products for cell culture, including full-length human recombinant laminins for 2D and 3D applications.
BioLamina, based in Stockholm, Sweden, has 1 investor on file, among them Lauxera Capital Partners. Its latest round on record is Debt, 17 Apr 2026. Its site was last checked 6 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Lauxera Capital Partners
13 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (93%), Cybersecurity (7%).
See Lauxera Capital Partners' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get BioLamina and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Lauxera Capital Partners adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/biolamina.com/investors
# also
GET /v1/companies/biolamina.com
GET /v1/companies/biolamina.com/news